-
艾媒咨询|2020年4-5月中国房地产行业月度运行数据监测报告
综合2020年4-5月,中国70个大中城市商品住宅销售价格变动统计数据发现,这一期间各线城市新建商品住宅销售价格环比涨幅均略有扩大,但价格相较去年同期仍有所回落。艾媒咨询分析师认为,在国家“只住不炒”的住房政策影响下,各城市的房价均受到控制,尽管受到新冠疫情影响住房需求量略有增长,但总体较为稳定。
Comprehensive April-May 2020, China's 70 large and medium-sized cities commercial housing sales price changes statistics found that during this period, the sales price of newly built commercial housing in various cities increased slightly, but the price is still higher than the same period last year Fall back.iiMedia Research believe that under the influence of the country's housing policy of "only live and not speculate", the housing prices of all cities are controlled. Although the housing demand has slightly increased due to the impact of the new crown epidemic, it is generally stable. -
艾媒报告|2020年中国后疫时代医疗防护行业及细分领域分析报告
本报告研究涉及企业/品牌/案例:欣龙控股,振德医疗,奥美医疗,尚荣医疗,际华集团,蓝帆医疗,兵装集团;其他提及企业/品牌:金三发科技,中国石油,赢合科技,鑫台铭,斯凯瑞,CM朝美,华东医药,爱马斯,海王星辰,北京同仁堂,拼多多,天猫,京东,上海通用五菱,比亚迪,龙头股份,华纺股份,水星家纺,红豆股份
2020年4月3日,全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020年中国后疫时代医疗防护行业及细分领域分析报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据,对2020年中国医疗防护行业及其细分领域的口罩、防护服、手套、护目镜等进行分析。此外,报告探讨产业上下游的运营模式,结合对欣龙控股、振德医疗、奥美医疗、尚荣医疗、际华集团、蓝帆医疗和兵装集团等典型企业的案例分析,对钢铁行业总体运行情况进行分析,并结合新冠疫情对2020-2021年中国医疗防护产业发展进行趋势预判。相较于发达国家,中国的医疗防护行业起步晚,防护水平低,由于医疗防护用品属于低值耗材,所以国内市场的品牌化理念也不强。但是,随着近些年中国经济的发展,国内的医疗防护市场逐渐升温,新老企业都有了品牌意识。在未来的发展道路上,品牌化和专业化将成为国内医疗防护用品生产企业的核心竞争力。
The outbreak of new crown pneumonia has raised awareness of personal protection, and the market potential for medical protective supplies is huge, and China's demand for medical protective equipment such as masks and gloves is expected to grow rapidly. In addition, the global outbreak of the new crown has also become a great opportunity for the export of China's medical protection products. As the first region to erupt in the outbreak, China has the first advantage of medical protective supplies, and the production capacity of medical protective supplies can be exported overseas. -
艾媒报告|2019-2020中国联合办公行业白皮书
本报告研究涉及企业/品牌/案例:氪空间,优客工场,梦想加,Bee+,纳什空间,ATLAS 寰图,wework中国,WE+酷窝,SOHO 3Q,滴滴出行,字节跳动,快手,新氧美容,五粮液,中粮集团,顺丰速递,中民投,IDG资本,普思资本,前海梧桐,鸥翎,愉悦资本,M31 Management,山东国惠,丝路华创,高瓴资本,泛大西洋,景荣控股,路劲产业,全明星投资,易凯资本,龙熙房地产,IDG资本,歌斐资本,逸星资本,Ocean Link ,珠海大横琴集团
iiMedia Research(艾媒咨询)数据显示,联合办公行业市场规模约为1267.2亿元,预计到2022年有望突破4000亿元。2019年中国联合办公行业经历深度洗牌,行业由大规模扩张转向精细化运营阶段,品牌之间呈现分化趋势,拥有精细化运营管理能力的品牌更具发展潜力。在综合竞争力方面,梦想加、优客工场、wework中国位列前三。在租户使用联合办公产品的联合调查中,66.7%的受访租户表示提升效率是主要原因;40.2%的租户因灵活便利而选择联合办公产品;30.4%的租户透露节约成本是其使用联合办公产品的主要原因。艾媒咨询分析认为,未来随着产品服务质量提高,市场接受度趋于上升,在智能技术的加持下,办公环境将走向高效智能化。
According to the data of iiMedia Research, the market size of the Joint Office Industry is about 126.72 billion yuan, and it will exceed 400 billion yuan in 2022. In 2019, the Joint Office Industry in China has undergone in-depth reshuffle. The industry has shifted from a large-scale expansion to a refined operation stage. Brands are showing a trend of differentiation. The stronger the refined operation management capabilities, the greater the brand's development potential. In terms of comprehensive competitiveness, Mydreamplus, Ucommune, and Wework China are among the top three. In the survey of the reasons for tenants using co-working products, 66.7% of the interviewed tenants stated that high efficiency was the main reason; 40.2% of the tenants chose co-working products for its flexibility and convenience; 30.4% of the tenants revealed that cost savings are the main reason for using co-working products. iiMedia consulting analysts believe that in the future, with the improvement of product and service quality, the acceptance of co-working market tends to rise. With the blessing of intelligent technology, the office environment will move towards efficient and intelligent. -
艾媒报告|2019年12月中国房地产行业月度运行数据监测报告
本报告研究涉及企业/品牌/案例:碧桂园,万科,中国恒大,融创中国,保利地产,绿地控股,中海地产,新城控股,世茂房地产,华润置地,龙湖集团,中国奥园,滨江集团,富力地产,融创中国,美的置业,荣盛发展,当代置业,世联行,中国雄安集团,Rentomojo,装店易,居然之家,中指控股,公装云,homelane,SiteMinder,安歆集团,新湖房地产,Zeus Living,Zolostays,Virgil,宝家乡墅,斯维登集团,GMO Payment Gateway,五格货栈,MFund魔量基金,房天下,青橙资本,FJ Labs,Sequoia Capital(红杉海外),Accel Partners,凯雷亚洲基金,绿城中国,Alumni Ventures Group,CEAS Investments,Initialized Capital,中力资本,Trifecta Capital,Kima Ventures,Alven Capital,Zoopla,58产业基金
从2019年各月中国房地产开发投资情况来看,中国房地产开发累计投资增速,以及房地产住宅投资累计增长速度都呈下降趋势。2019年1—12月份,中国房地产开发企业到位资金178609亿元,同比增长7.6%。其中,国内贷款增长5.1%,外资增长62.7%,自筹资金增长4.2%,定金及预收款增长10.7%,个人按揭贷款增长15.1%。艾媒咨询分析师认为,以往国家降准松动资金后,资金最先会流向的领域是房地产行业,而在2019年频繁发布的房市紧缩政策的背景下,保证资金用于促进市场活力而非再大量注入市场,财政宽松政策对房地产业的利好有限。
From the perspective of China's real estate development investment in each month of 2019, the cumulative growth rate of China's real estate development investment and the cumulative growth rate of real estate and residential investment have shown a downward trend. From January to December 2019, the funds in place for Chinese real estate development enterprises reached 17.86 trillion yuan, a year-on-year increase of 7.6%. Among them, domestic loans increased by 5.1%, foreign capital increased by 62.7%, self-raised funds increased by 4.2%, deposits and advance receipts increased by 10.7%, and personal mortgage loans increased by 15.1%. Ai Media Consulting analysts believe that after the country lowered its funds in the past, the first area that funds will flow to is the real estate industry, and in the context of the frequently tightened housing market policy issued in 2019, it is guaranteed that funds will be used to promote market vitality rather than A large number of injections into the market, fiscal easing policies have limited benefits to the real estate industry. -
艾媒报告|2019-2021年中国中药材行业发展现状及产业链分析报告
本报告研究涉及企业/品牌/案例:白云山,同仁堂,云南白药,昆明制药,华润三九,天士力,央视财经,牛黄,薏仁,茯苓,黄芪,川芎,片仔癀,中国中药,紫鑫药业,九洲药业,陇神戎发,众生药业,通化金马,江中药业,寿仙谷,新天药业,盘龙药业,佛慈制药,昆药集团,香雪制药,六味地黄丸,人参养荣丸,四神丸,白蚀丸,血脂康胶囊,茵栀黄口服液,一捻金胶囊,乙肝益气解郁颗粒,二十七味定坤丸,十六味冬青丸,参芪消渴胶囊,十香返生丸,华润三九,红日药业,源和药业,太龙药业,中智药业,培力控股,盛实百草,芍花堂,亳药千草,汇群中药
国内经济增长以及居民消费水平的提高都刺激着中药医疗消费需求的增长。iiMedia Research(艾媒咨询)调查显示,有49%的受访用户倾向中医药治疗,与西药基本持平。2018年中国中药材市场规模达1246亿元,同比增长22.40%,在巨大的需求驱动下,中药材种植面积扩大,药材产量将会持续增长。
中药材主要包括上游种植、养殖市场,中游流通市场和下游销售市场三大环节。目前,中药饮片和中成药生产是中药产业的核心,主要包括中药加工,包括中药配方颗粒、中药饮片加工、中成药制造等。中药饮片领域方面,行业销售收入增速分别在2016和2018年触底回升,华润三九、中国中药、红日药业等上市公司表现良好;中药配方颗粒方面,2006-2016年,中国市场销售额占饮片市场销售额比重由1.2%增加至6.0%,中药配方颗粒或将成为中药饮片加工行业应用广泛的产品;中成药方面,随着国家医改政策的推行,中成药消费需求趋于合理,中成药产量开始回落,但仍处于一个比较高的产量水平,云南白药、白云山、同仁堂、紫鑫药业等上市企业表现良好。
Chinese medicinal materials mainly include upstream planting, breeding market, midstream circulation market and downstream sales market three links. At present, the production of Chinese medicine tablets and traditional Chinese medicine is the core of the Chinese medicine industry, including the processing of Traditional Chinese medicine, including Chinese medicine formula particles, Chinese medicine tablet processing, traditional Chinese medicine manufacturing. In the field of Chinese medicine tablets, the growth rate of sales revenue in the industry rebounded in 2016 and 2018, respectively, china Resources 39, Chinese medicine, Red Day Pharmaceuticals and other listed companies performed well; Chinese medicine formula particles may become a widely used product in the Chinese medicine tablet processing industry, Chinese medicine, with the implementation of the national medical reform policy, the consumption demand of traditional Chinese medicine tends to be reasonable, the production of Traditional Chinese medicine began to fall, but still at a relatively high level of production, Yunnan White Medicine, Baiyunshan, Tongrentang, Zixin Pharmaceutical and other listed enterprises performed well. -
艾媒研报|优客工场:独角兽扩张快,“二房东”摘帽难
本报告研究涉及涉及企业/品牌/案例:氪空间、SOHO3Q和WeWork中国、纳什空间、红杉资本、真格基金、歌斐资产、亿润投资、中投汉富、创新工场、Keep、罗辑思维、得到、地平线机器人、OYO酒店、方正和生投资、无双资本、汉富资本、中投合众、翰同资本、永柏资本、鸿泰国银、青创客、领势投资、高和资本、银泰置地、中融信托、中国泰和集团、北京百福嘉工程管理有限公司、天弘基金、俊发地产集团、创合汇投资、普思资本、天明双创科技有限公司、大宏集团、首创置业、星牌集团、北京爱康集团、景荣控股、前海梧桐并购基金,中景恒基、场景基金、山东国惠、丝路华创、微店、玩多多、CoCo郁可茶饮、东风4S店、滴滴出行、小米、今日头条、盒马鲜生、蔚来汽车、美团、苏宁、七天酒店、平安银行、国家电网、泛优咨询、跑哪儿、知呱呱、企业盒子、AA加速器
数据显示,2018年中国市场主体数量1.1亿,其中中小企业数量超过7000万,它们对办公空间存在大量需求。伴随着经济的发展与观念的改变,企业对办公空间的需求逐渐呈现出成本降级、体验升级的特点。在这种背景下,联合办公空间以更能解决用户痛点、满足用户需求的模式对传统商业地产进行升级替代,并逐渐呈现出刚性的特征,预计2020年中国联合办公市场规模将突破2,000亿元。目前中国联合办公企业主要以互联网系初创企业以及部分地产系品牌为主,广泛布局在一线城市并不断向二线城市辐射。市场份额方面,头部玩家已占据近全国三分之一的份额,市场集中度有望进一步提升。优客工场作为中国联合办公领域的独角兽企业,凭借自身的资源整合能力以及规模优势呈现出巨大发展潜力,但其单一的营收结构、不稳定的现金流、亟待提升的运营管理能力都将是其战胜对手需要解决的重大难题。
The data shows that in 2018, the number of Chinese market entities was 110 million, of which the number of SMEs exceeded 70 million. They have a large demand for office space. Along with the economic development and the change of concept, the demand for office space of enterprises gradually shows the characteristics of cost reduction and experience upgrade. In this context, the joint office space upgrades and replaces traditional commercial real estate with a model that can better address user pain points and meet user needs, and gradually exhibits rigid characteristics. It is estimated that the scale of China's joint office market will exceed 200 billion yuan in 2020. . At present, China's joint office enterprises mainly focus on Internet-based start-ups and some real estate brands, which are widely distributed in first-tier cities and continue to radiate to second-tier cities. In terms of market share, head players have already occupied a third of the country's share, and market concentration is expected to increase further. As a unicorn enterprise in the joint office field in China, Ucommune has great potential for development due to its own resource integration capability and scale advantage, but its single revenue structure, unstable cash flow, and operational management capabilities will be the major problems that need to be solved to overcome its opponents. -
艾媒研报|科创板:2019年科创板受理企业及影子股分析研究报告
本报告研究涉及企业/品牌包括:科前生物、安翰科技、和舰芯片、容百科技、利元亨、江苏北人、天奈科技、睿创微纳、晶晨股份、贝斯达、华兴源创、微芯生物、特宝生物、国盾量子、虹软科技、世纪空间、光峰科技、福光股份、鸿泉物联、木瓜移动、优刻得、博众精工、创鑫激光、聚辰股份、海尔生物、天准科技、晶丰明源、申联生物、南微医学、美迪西、紫晶存储、苑东生物、恒安嘉新、乐鑫科技、龙软科技、杰普特、热景生物、瀚川智能、威胜信息、安博通、铂力特、视联动力、博瑞医药
2019年3月份科创板受理的企业包括:科前生物、安翰科技、和舰芯片、容百科技、利元亨、江苏北人、天奈科技、睿创微纳、晶晨股份、贝斯达、华兴源创、微芯生物、特宝生物、国盾量子、虹软科技、世纪空间、光峰科技、福光股份、鸿泉物联、木瓜移动等 2019年4月份受理的企业包括:优刻得、博众精工、创鑫激光、聚辰股份、海尔生物、天准科技、晶丰明源、申联生物、南微医学、美迪西、紫晶存储、苑东生物、恒安嘉新、乐鑫科技、龙软科技、杰普特、热景生物、瀚川智能、威胜信息、安博通、铂力特、视联动力、博瑞医药等,相应的重点影子股包括: TCL集团、华域汽车、天风证券、通化东宝、千方科技等。
In March and April 2019, the science and technology innovation board accepted the following enterprises: Wuhan Keqian Biology Co,Ltd, Ankon Technologies Co. Ltd, Hejian Technology (Suzhou) Co, Ltd, Ningbo Ronbay New Energy Technology Co, Ltd, Guangdong Lyric Robot Automation Co, Ltd, Jiangsu Beiren Robot System Co,Ltd, Jiangsu Cnano Technology Co, Ltd,Raytron Technology Co,Ltd,Amlogic (Shanghai) Co,Ltd, Shenzhen Basda Medical Apparatus Co,Ltd,Suzhou Hyc Technology Co,Ltd , etc. In April 2019, the science and technology innovation board accepted the following enterprises: Montage Technology Co, Ltd, UCloud Technology Co, Ltd, Bozhon Precision Industry Technology Co,Ltd, Shanghai Shen Lian Biomedical Corporation, Shanghai Bright Power Semiconductor Co, Ltd, Suzhou Tztek Technology Co,Ltd, Giantec Semiconductor Corporation, QINGDAO HAIER BIOMEDICAL CO, LTD. , MAXPHOTONICS Co, Ltd, Amethystum Storage Technology Co,Ltd , etc.
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告